These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20950304)

  • 21. Sildenafil citrate efficacy 8 h postdose in men with mild to moderate erectile dysfunction.
    McCullough AR; Steidle CP; Kaufman J; Goldfischer ER; Klee B; Carlsson M
    Int J Impot Res; 2008; 20(4):388-95. PubMed ID: 18528401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erectile dysfunction medication use among men seeking substance abuse treatment.
    Horvath KJ; Calsyn DA; Terry C; Cotton A
    J Addict Dis; 2007; 26(4):7-13. PubMed ID: 18032227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile dysfunction.
    Wessells H; Joyce GF; Wise M; Wilt TJ
    J Urol; 2007 May; 177(5):1675-81. PubMed ID: 17437781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of improved erectile function and rate of successful intercourse with improved emotional well-being assessed with the Self-Esteem And Relationship questionnaire in men treated with sildenafil for erectile dysfunction and stratified by age.
    Steidle CP; Stecher VJ; Pace C; Tseng LJ;
    Curr Med Res Opin; 2006 May; 22(5):939-48. PubMed ID: 16709315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
    Müller A; Smith L; Parker M; Mulhall JP
    BJU Int; 2007 Jul; 100(1):117-21. PubMed ID: 17552959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and cardiovascular comorbidities.
    Vicari E; Malaguarnera M; La Vignera S; Calzavara F; Battiato C; Calogero AE
    Asian J Androl; 2008 Nov; 10(6):847-53. PubMed ID: 18958348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDE5 inhibitors for erectile dysfunction revisited.
    Med Lett Drugs Ther; 2012 Feb; 54(1383):10-1. PubMed ID: 22354220
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial.
    Sommer F; Klotz T; Engelmann U
    Asian J Androl; 2007 Jan; 9(1):134-41. PubMed ID: 17187165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The safety of 5-phosphodiesterase inhibitors in the treatment of erectile dysfunction in patients with cardiovascular disease].
    Bryniarski L; Rzepecki M; Klocek M; Wyczołkowski M
    Przegl Lek; 2009; 66(4):192-7. PubMed ID: 19708509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil.
    Dadkhah F; Safarinejad MR; Asgari MA; Hosseini SY; Lashay A; Amini E
    Int J Impot Res; 2010; 22(1):51-60. PubMed ID: 19865092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erectile dysfunction: evaluation and new treatment options.
    Carson CC
    Psychosom Med; 2004; 66(5):664-71. PubMed ID: 15385689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erectile dysfunction and viagra use: what's up with college-age males?
    Musacchio NS; Hartrich M; Garofalo R
    J Adolesc Health; 2006 Sep; 39(3):452-4. PubMed ID: 16919814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Happy birthday Viagra.
    Muench PJ
    Del Med J; 2012 May; 84(5):157-9. PubMed ID: 22866386
    [No Abstract]   [Full Text] [Related]  

  • 35. [Efficacy and safety of vardenafil in men with erectile dysfunction and depression].
    Hu L
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):876-9. PubMed ID: 15595695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Update of PDE5 inhibitors as treatment of ED].
    Lu YN; Chen B
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):552-5. PubMed ID: 16078679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of erectile dysfunction in the primary care setting: importance of risk factors for diabetes and vascular disease.
    Grover SA; Lowensteyn I; Kaouache M; Marchand S; Coupal L; DeCarolis E; Zoccoli J; Defoy I
    Arch Intern Med; 2006 Jan; 166(2):213-9. PubMed ID: 16432091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erectile dysfunction and comorbid diseases, androgen deficiency, and diminished libido in men.
    Fine SR
    J Am Osteopath Assoc; 2004 Jan; 104(1 Suppl 1):S9-15. PubMed ID: 14992321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vardenafil for the treatment of erectile dysfunction in men with diabetes].
    Wang X
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):794-7. PubMed ID: 15562798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sildenafil citrate improves erectile function: a randomised double-blind trial with open-label extension.
    McVary KT; Kaufman J; Young JM; Tseng LJ
    Int J Clin Pract; 2007 Nov; 61(11):1843-9. PubMed ID: 17887993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.